On June 14, 2024, Andrew Regan, associated with Conduit Pharmaceuticals (CDT.US), engaged in a series of stock transactions. Regan completed the sale of 1,100,000 shares of common stock, which was followed by multiple disposals totaling 16,401,068 shares between July 3, 2024, and July 17, 2024. The sales occurred over a range of prices, with the lowest at $0.2471 and the highest at $0.3169 per share. After these transactions, Regan's holdings in Conduit Pharmaceuticals decreased to 177,627 shares of common stock. The transactions were carried out in the open market or through private sales, as indicated by the transaction code 'S'.

On June 14, 2024, Andrew Regan, associated with Conduit Pharmaceuticals (CDT.US), engaged in a series of stock transactions. Regan completed the sale of 1,100,000 shares of common stock, which was followed by multiple disposals totaling 16,401,068 shares between July 3, 2024, and July 17, 2024. The sales occurred over a range of prices, with the lowest at $0.2471 and the highest at $0.3169 per share. After these transactions, Regan's holdings in Conduit Pharmaceuticals decreased to 177,627 shares of common stock. The transactions were carried out in the open market or through private sales, as indicated by the transaction code 'S'.